Shares ofDr Reddy’s Laboratories (DRL) today surged 6.5 per cent after the company launched the generic version of Astrazeneca’s Nexium, used to treat acid reflux, in the US market.
The s…
Subscribe To Our Free Newsletter |
Shares ofDr Reddy’s Laboratories (DRL) today surged 6.5 per cent after the company launched the generic version of Astrazeneca’s Nexium, used to treat acid reflux, in the US market.
The s…
Subscribe To Our Free Newsletter |
EvoLve theme by Theme4Press • Powered by WordPress & Rakesh Jhunjhunwala Latest Stock Market News
The Most Valuable Commodity Is Information!